🇺🇸 FDA
Pipeline program

TAK-117

MLN1117-1002

Phase 1 small_molecule completed

Quick answer

TAK-117 for Neoplasm, Advanced or Metastatic is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Neoplasm, Advanced or Metastatic
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials